0001237899-11-000030.txt : 20110405 0001237899-11-000030.hdr.sgml : 20110405 20110405164243 ACCESSION NUMBER: 0001237899-11-000030 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110404 FILED AS OF DATE: 20110405 DATE AS OF CHANGE: 20110405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STAHL NEIL CENTRAL INDEX KEY: 0001226689 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 11740578 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 4 1 edgardoc.xml PRIMARY DOCUMENT X0303 4 2011-04-04 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001226689 STAHL NEIL 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 SVP Res and Dev Sciences Common Stock 2011-04-04 4 M 0 92308 13 A 142658 D Common Stock 2011-04-04 4 F 0 26356 45.53 D 116302 D Common Stock 2011-04-04 4 F 0 31837 45.53 D 84465 D Common Stock 2011-04-05 4 S 0 11200 45.83 D 73265 D Common Stock 2011-04-05 4 S 0 22915 46.23 D 50350 D Common Stock 5335 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 13 2011-04-04 4 M 0 92308 D 2013-12-15 Common Stock 92308 0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). The reporting person sold 11,200 shares of Company stock on April 5, 2011 at prices ranging from $45.56 to $45.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 5, 2011 at each separate price. The reporting person sold 22,915 shares of Company stock on April 5, 2011 at prices ranging from $46.00 to $46.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 5, 2011 at each separate price. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case. /s/**Neil Stahl 2011-04-05